Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Manufactures pharmaceuticals

Develops pharmaceuticals and conducts biomedical research

Beijing Cornerstone Life Technology Co., Ltd., established on 2016-06-20, Business scope includes technical services,Technology Promotion;Conference Services;computer technology training(Cannot be recruited nationwide);software development,computer repair;Computer System Services;Economic and Trade Consulting;Sales of chemical products(Does not contain dangerous chemicals and a class of precursor chemicals),electronic product,Equipment,computer,Software and Auxiliary Equipment;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Import and export,Agent import and export,Technology Import and Export;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

At INEX, they understand that women's health needs evolve and change throughout her life; They specialise in FemTech – technology that addresses specific concerns on women’s health, such as reproductive health and ovarian cancer.They aim improve women’s access to non-invasive healthcare and want to equip women to manage the range of conditions they face at certain stages of their lives, from adulthood to pregnancy and maturity in later years.Their iGene Laboratory delivers results to help clinicians diagnose and help women in pregnancy and health.Their Cancer Diagnostic solutions gives clinicians the power to predict and assess conditions associated with ovarian cancer.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Puri Benchmark Biomedicine (Suzhou) Co., Ltd., established on 2018-09-14, Business scope includes biomedicine,R&D of medical devices,Production,Sales;biotechnology development,technical consulting,technology transfer,Technical Services;laboratory consumables,experimental reagent(Does not contain hazardous chemicals),Instrumentation(No measuring vessel),Sales of computer software, hardware and auxiliary equipment;Engage in the import and export of the above commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yamasa Corp. manufactures and supplies soy sauce and seasonings. It processes and supplies soy sauce, seasonings, sauces, dips, and flavorings. The firm also develops pharmaceuticals and biochemicals. The company was founded in 1645 and is headquartered in Choshi, Japan.

Shanghai Aiqi Ecological Technology Co., Ltd., established on 1997-08-26, The scope of business includes engaging in ecological and environmental protection,Biotechnology,new building materials,Technology development in the field of computer software and hardware technology,technology transfer,Technical Services,Green facilities,Sales of building materials. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

The history of Self-screen is a track record in translational science. The company was founded in 2008 to advance the implementation of scientific discoveries in the field of cancer screening into routine practice. Our dedication is towards the development and clinical application of molecular assays for the early detection of cancer, thereby to the benefit of patients around the world. Currently, the company’s main focus is on cervical cancer screening and prevention. The company has two clinically validated assays on the market. We strive towards all-molecular screening to ensure objectivity, reproducibility and high-throughput possibilities. Our research and development pipeline currently focuses on the extension of our science towards other sample types, like urine, and towards other cancer types.

Takasago International Corp. engages in the manufacture and sale of flavors, fragrances, aroma ingredients, and fine chemicals. It operates through the following regional segments: Japan, America, Europe, and Asia. All of the segments handle flavor, fragrances, and aroma ingredients. The Japan segment also deals with fine chemicals and offer real estate leasing and other services. The America Segment also sells fine chemicals. The company was founded by Nanko Kaisho on February 09, 1920 and is headquartered in Tokyo, Japan.

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

VBL Therapeutics is an innovative and diversified, clinical stage biotechnology company committed to the discovery, development and commercialization of novel treatments for cancer and immune-inflammatory diseases. Currently available therapies are limited in their ability to adequately treat these serious and oftentimes life-threatening diseases. VBL was founded to create new treatment options that address these unmet medical needs. VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. To date, VBL has developed two programs based on these platforms – an oncology program and an anti-inflammatory program.

Axelar AB is a Swedish biotechnology company that was founded in 2003 by Professor Magnus Axelson, Professor Olle Larsson and Karolinska Innovations AB/Karolinska Development AB. The company focuses its research and other activities on inhibitors of the insulin-like growth factor-1 (IGF-1) receptor and their applications in important human diseases, especially cancer. Axelar AB is situated in the Karolinska Institutet Science Park, Stockholm, Sweden.

Abraxis BioScience LLC, part of Bristol Myers Squibb Co., is a company headquartered in Los Angeles, CA, involved in commercial physical and biological research.

Beijing Pukang Ruiren Medical Laboratory Co., Ltd., established on 2015-11-27, Business scope includes medical laboratory services;technical consulting,technology development,Technical Services,technology transfer;Sales of laboratory instruments,Laboratory Chemical Reagents(Free of Hazardous Chemicals),Computer hardware and software and peripheral equipment(Excluding special products for computer information system security);Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)